Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT

Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin r...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2015-06, Vol.40 (6), p.496-498
Main Authors: Arora, Saurabh, Soundararajan, Ramya, Joshi, Prashant, Kumar, Rakesh, Bal, Chandrasekhar
Format: Article
Language:English
Subjects:
Female
Humans
Multimodal Imaging
Neuroendocrine Tumors - diagnostic imaging
Neuroendocrine Tumors - pathology
Organometallic Compounds
Ovarian Neoplasms - diagnostic imaging
Ovarian Neoplasms - secondary
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 498
container_issue 6
container_start_page 496
container_title Clinical nuclear medicine
container_volume 40
creator Arora, Saurabh
Soundararajan, Ramya
Joshi, Prashant
Kumar, Rakesh
Bal, Chandrasekhar
description Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by Ga-labeled DOTANOC ([1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by Ga DOTANOC PET/CT imaging.
doi_str_mv 10.1097/RLU.0000000000000646
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680183447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1680183447</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-7e8f3cfa23b20cf7e26d1244cbef8b480af2ef4ec1b85aea091605d0a5ea51053</originalsourceid><addsrcrecordid>eNpNkE1Lw0AURQdBbK3-A5FZ1kXaN5OZSbossVahWNF0HV6SF4nky5mp2H9vwQrezd2ccxeXsRsBMwGLaP662c3gf4wyZ2wsdGgCkHIxYpfOfQAII4y6YCOptTISYMyyt75F3zuPvu64pYIG31tO34Ml5-runed1g54sNrz_Qltjx1vyeBQcOV6Sp8JTyfMDn5r4bo38fpsun7cJf1ml8yS9YucVNo6uTz1hu4dVmjwGm-36KVlugkFI44OI4iosKpRhLqGoIpKmFFKpIqcqzlUMWEmqFBUijzUSwkIY0CWgJtQCdDhh09_dwfafe3I-a2tXUNNgR_3eZcLEIOJQqeiI3p7Qfd5SmQ22btEesr9Twh_QcWKf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680183447</pqid></control><display><type>article</type><title>Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Arora, Saurabh ; Soundararajan, Ramya ; Joshi, Prashant ; Kumar, Rakesh ; Bal, Chandrasekhar</creator><creatorcontrib>Arora, Saurabh ; Soundararajan, Ramya ; Joshi, Prashant ; Kumar, Rakesh ; Bal, Chandrasekhar</creatorcontrib><description>Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by Ga-labeled DOTANOC ([1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by Ga DOTANOC PET/CT imaging.</description><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0000000000000646</identifier><identifier>PMID: 25546200</identifier><language>eng</language><publisher>United States</publisher><subject>Female ; Humans ; Multimodal Imaging ; Neuroendocrine Tumors - diagnostic imaging ; Neuroendocrine Tumors - pathology ; Organometallic Compounds ; Ovarian Neoplasms - diagnostic imaging ; Ovarian Neoplasms - secondary ; Positron-Emission Tomography ; Radiopharmaceuticals ; Tomography, X-Ray Computed</subject><ispartof>Clinical nuclear medicine, 2015-06, Vol.40 (6), p.496-498</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25546200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arora, Saurabh</creatorcontrib><creatorcontrib>Soundararajan, Ramya</creatorcontrib><creatorcontrib>Joshi, Prashant</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bal, Chandrasekhar</creatorcontrib><title>Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by Ga-labeled DOTANOC ([1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by Ga DOTANOC PET/CT imaging.</description><subject>Female</subject><subject>Humans</subject><subject>Multimodal Imaging</subject><subject>Neuroendocrine Tumors - diagnostic imaging</subject><subject>Neuroendocrine Tumors - pathology</subject><subject>Organometallic Compounds</subject><subject>Ovarian Neoplasms - diagnostic imaging</subject><subject>Ovarian Neoplasms - secondary</subject><subject>Positron-Emission Tomography</subject><subject>Radiopharmaceuticals</subject><subject>Tomography, X-Ray Computed</subject><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpNkE1Lw0AURQdBbK3-A5FZ1kXaN5OZSbossVahWNF0HV6SF4nky5mp2H9vwQrezd2ccxeXsRsBMwGLaP662c3gf4wyZ2wsdGgCkHIxYpfOfQAII4y6YCOptTISYMyyt75F3zuPvu64pYIG31tO34Ml5-runed1g54sNrz_Qltjx1vyeBQcOV6Sp8JTyfMDn5r4bo38fpsun7cJf1ml8yS9YucVNo6uTz1hu4dVmjwGm-36KVlugkFI44OI4iosKpRhLqGoIpKmFFKpIqcqzlUMWEmqFBUijzUSwkIY0CWgJtQCdDhh09_dwfafe3I-a2tXUNNgR_3eZcLEIOJQqeiI3p7Qfd5SmQ22btEesr9Twh_QcWKf</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Arora, Saurabh</creator><creator>Soundararajan, Ramya</creator><creator>Joshi, Prashant</creator><creator>Kumar, Rakesh</creator><creator>Bal, Chandrasekhar</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT</title><author>Arora, Saurabh ; Soundararajan, Ramya ; Joshi, Prashant ; Kumar, Rakesh ; Bal, Chandrasekhar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-7e8f3cfa23b20cf7e26d1244cbef8b480af2ef4ec1b85aea091605d0a5ea51053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Female</topic><topic>Humans</topic><topic>Multimodal Imaging</topic><topic>Neuroendocrine Tumors - diagnostic imaging</topic><topic>Neuroendocrine Tumors - pathology</topic><topic>Organometallic Compounds</topic><topic>Ovarian Neoplasms - diagnostic imaging</topic><topic>Ovarian Neoplasms - secondary</topic><topic>Positron-Emission Tomography</topic><topic>Radiopharmaceuticals</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arora, Saurabh</creatorcontrib><creatorcontrib>Soundararajan, Ramya</creatorcontrib><creatorcontrib>Joshi, Prashant</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bal, Chandrasekhar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arora, Saurabh</au><au>Soundararajan, Ramya</au><au>Joshi, Prashant</au><au>Kumar, Rakesh</au><au>Bal, Chandrasekhar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2015-06</date><risdate>2015</risdate><volume>40</volume><issue>6</issue><spage>496</spage><epage>498</epage><pages>496-498</pages><eissn>1536-0229</eissn><abstract>Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by Ga-labeled DOTANOC ([1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by Ga DOTANOC PET/CT imaging.</abstract><cop>United States</cop><pmid>25546200</pmid><doi>10.1097/RLU.0000000000000646</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1536-0229
ispartof Clinical nuclear medicine, 2015-06, Vol.40 (6), p.496-498
issn 1536-0229
language eng
recordid cdi_proquest_miscellaneous_1680183447
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Female
Humans
Multimodal Imaging
Neuroendocrine Tumors - diagnostic imaging
Neuroendocrine Tumors - pathology
Organometallic Compounds
Ovarian Neoplasms - diagnostic imaging
Ovarian Neoplasms - secondary
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed
title Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A41%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Somatostatin%20receptor%20expressing%20bilateral%20ovarian%20metastases%20detected%20by%20(68)Ga%20DOTANOC%20PET/CT&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Arora,%20Saurabh&rft.date=2015-06&rft.volume=40&rft.issue=6&rft.spage=496&rft.epage=498&rft.pages=496-498&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0000000000000646&rft_dat=%3Cproquest_pubme%3E1680183447%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p126t-7e8f3cfa23b20cf7e26d1244cbef8b480af2ef4ec1b85aea091605d0a5ea51053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1680183447&rft_id=info:pmid/25546200&rfr_iscdi=true